Bristol, Merck, AbbVie face House committee probe over China trials
Covered by 2 sources · 2 articles
2 outlets - including Thestreet and Seekingalpha - are covering this story. Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China sent letters this week to Merck (MRK), AbbVie (ABBV), Eli Lilly (LLY), Pfizer (PFE), and Bristol Myers Squibb (BMY), Reute…
Covered by
All coverage
House committee investigates Merck, AbbVie over China trials
Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China sent letters this week to Merck (MRK), AbbVie (ABBV), Eli Lilly (LLY), Pfizer (PFE), and Bristol Myers Squibb (BMY), Reute…
Bristol, Merck, AbbVie face House committee probe over China trials